82
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Prevalence, risk factors and prognostic value of anxiety and depression in recurrent glioma patients

&
Pages 2474-2485 | Received 08 Sep 2022, Accepted 30 May 2023, Published online: 04 Jun 2023

References

  • Burnet, N. G., Lynch, A. G., Jefferies, S. J., Price, S. J., Jones, P. H., Antoun, N. M., Xuereb, J. H., & Pohl, U. (2007). High grade glioma: Imaging combined with pathological grade defines management and predicts prognosis. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology, 85(3), 371–378. https://doi.org/10.1016/j.radonc.2007.10.008
  • Chen, W., Lei, C., Liu, P., Liu, Y., Guo, X., Kong, Z., Wang, Y., Dai, C., Wang, Y., Ma, W., & Wang, Y. (2020). Progress and prospects of recurrent glioma: A recent scientometric analysis of the web of science in 2019. World Neurosurgery, 134, e387–e399. https://doi.org/10.1016/j.wneu.2019.10.078
  • D’Angelo, C., Mirijello, A., Leggio, L., Ferrulli, A., Carotenuto, V., Icolaro, N., Miceli, A., D’Angelo, V., Gasbarrini, G., & Addolorato, G. (2008). State and trait anxiety and depression in patients with primary brain tumors before and after surgery: 1-year longitudinal study. Journal of Neurosurgery, 108(2), 281–286. https://doi.org/10.3171/JNS/2008/108/2/0281
  • Davis, M. E. (2018). Epidemiology and overview of gliomas. Seminars in Oncology Nursing, 34(5), 420–429. https://doi.org/10.1016/j.soncn.2018.10.001
  • Davis, N. E., Hue, J. J., Kyasaram, R. K., Elshami, M., Graor, H. J., Zarei, M., Ji, K., Katayama, E. S., Hajihassani, O., Loftus, A. W., Shanahan, J., Vaziri-Gohar, A., Rothermel, L. D., & Winter, J. M. (2022). Prodromal depression and anxiety are associated with worse treatment compliance and survival among patients with pancreatic cancer. Psychooncology, 31(8), 1390–1398. https://doi.org/10.1002/pon.5945
  • Diamond, E. L., Prigerson, H. G., Correa, D. C., Reiner, A., Panageas, K., Kryza Lacombe, M., Buthorn, J., Neil, E. C., Miller, A. M., DeAngelis, L. M., & Applebaum, A. J. (2017). Prognostic awareness, prognostic communication, and cognitive function in patients with malignant glioma. Neuro-Oncology, 19(11), 1532–1541. https://doi.org/10.1093/neuonc/nox117
  • Donner, N. C., & Lowry, C. A. (2013). Sex differences in anxiety and emotional behavior. Pflugers Archiv: European Journal of Physiology, 465(5), 601–626. https://doi.org/10.1007/s00424-013-1271-7
  • Finch, A., Solomou, G., Wykes, V., Pohl, U., Bardella, C., & Watts, C. (2021). Advances in research of adult gliomas. International Journal of Molecular Sciences, 22(2), 924. https://doi.org/10.3390/ijms22020924
  • Fu, X., Wu, C., Han, N., Liu, N., Han, S., Liu, X., Li, S., & Yan, C. (2020). Depressive and anxiety disorders worsen the prognosis of glioblastoma. Aging (Albany NY), 12(20), 20095–20110. https://doi.org/10.18632/aging.103593
  • Hamam, M. S., Kunjummen, E., Hussain, M. S., Nasereldin, M., Bennett, S., & Miller, J. (2020). Anxiety, depression, and Pain: Considerations in the treatment of patients with uncontrolled hypertension. Current Hypertension Reports, 22(12), 106. https://doi.org/10.1007/s11906-020-01117-2
  • Hao, A., Huang, J., & Xu, X. (2021). Anxiety and depression in glioma patients: Prevalence, risk factors, and their correlation with survival. Irish Journal of Medical Science, 190(3), 1155–1164. https://doi.org/10.1007/s11845-020-02374-5
  • Hart, M. G., Garside, R., Rogers, G., Stein, K., & Grant, R. (2013). Temozolomide for high grade glioma. Cochrane Database Syst Rev, 2013(4), CD007415. https://doi.org/10.1002/14651858.CD007415.pub2
  • Jackson, C., Westphal, M., & Quinones-Hinojosa, A. (2016). Complications of glioma surgery. Handbook of Clinical Neurology, 134, 201–218. https://doi.org/10.1016/B978-0-12-802997-8.00012-8
  • Liblik, K., Mulvagh, S. L., Hindmarch, C. C. T., Alavi, N., & Johri, A. M. (2022). Depression and anxiety following acute myocardial infarction in women. Trends in Cardiovascular Medicine, 32(6), 341–347. https://doi.org/10.1016/j.tcm.2021.07.005
  • Lin, D., Wang, M., Chen, Y., Gong, J., Chen, L., Shi, X., Lan, F., Chen, Z., Xiong, T., Sun, H., & Wan, S. (2021). Trends in intracranial glioma incidence and mortality in the United States, 1975-2018. Frontiers in Oncology, 11, 748061. https://doi.org/10.3389/fonc.2021.748061
  • Litofsky, N. S., Farace, E., Anderson, F., Jr., Meyers, C. A., Huang, W., Laws, E. R., Jr., & Glioma Outcomes Project, I. (2004). Depression in patients with high-grade glioma: Results of the glioma outcomes project. Neurosurgery, 54(2), 358–366. discussion 366-357. https://doi.org/10.1227/01.neu.0000103450.94724.a2.
  • Lombardi, G., Bergo, E., Del Bianco, P., Bellu, L., Pambuku, A., Caccese, M., Trentin, L., & Zagonel, V. (2018). Quality of life perception, cognitive function, and psychological status in a real-world population of glioblastoma patients treated with radiotherapy and temozolomide: A single-center prospective study. American Journal of Clinical Oncology, 41(12), 1263–1271. https://doi.org/10.1097/COC.0000000000000459
  • Louis, D. N., Perry, A., Reifenberger, G., von Deimling, A., Figarella-Branger, D., Cavenee, W. K., Ohgaki, H., Wiestler, O. D., Kleihues, P., & Ellison, D. W. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: A summary. Acta Neuropathologica, 131(6), 803–820. https://doi.org/10.1007/s00401-016-1545-1
  • Nabors, L. B., Portnow, J., Ahluwalia, M., Baehring, J., Brem, H., Brem, S., Butowski, N., Campian, J. L., Clark, S. W., Fabiano, A. J., Forsyth, P., Hattangadi-Gluth, J., Holdhoff, M., Horbinski, C., Junck, L., Kaley, T., Kumthekar, P., Loeffler, J. S. … Darlow, S. D. (2020). Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology. Journal of the National Comprehensive Cancer Network: JNCCN, 18(11), 1537–1570. https://doi.org/10.6004/jnccn.2020.0052
  • Nayak, L., & Reardon, D. A. (2017). High-grade gliomas. Continuum (Minneap Minn), 23(6, Neuro–oncology), 1548–1563. https://doi.org/10.1212/CON.0000000000000554
  • Norr, A. M., Albanese, B. J., Allan, N. P., & Schmidt, N. B. (2015). Anxiety sensitivity as a mechanism for gender discrepancies in anxiety and mood symptoms. Journal of Psychiatric Research, 62, 101–107. https://doi.org/10.1016/j.jpsychires.2015.01.014
  • Orgeta, V., Leung, P., Del-Pino-Casado, R., Qazi, A., Orrell, M., Spector, A. E., & Methley, A. M. (2022). Psychological treatments for depression and anxiety in dementia and mild cognitive impairment. Cochrane Database Syst Rev, 4(4), CD009125. https://doi.org/10.1002/14651858.CD009125.pub3
  • Rooney, A. G., Carson, A., & Grant, R. (2011). Depression in cerebral glioma patients: A systematic review of observational studies. Journal of the National Cancer Institute, 103(1), 61–76. https://doi.org/10.1093/jnci/djq458
  • Ryba, M. M., Lejuez, C. W., & Hopko, D. R. (2014). Behavioral activation for depressed breast cancer patients: The impact of therapeutic compliance and quantity of activities completed on symptom reduction. Journal of Consulting and Clinical Psychology, 82(2), 325–335. https://doi.org/10.1037/a0035363
  • Salk, R. H., Hyde, J. S., & Abramson, L. Y. (2017). Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms. Psychological Bulletin, 143(8), 783–822. https://doi.org/10.1037/bul0000102
  • Shi, C., Lamba, N., Zheng, L. J., Cote, D., Regestein, Q. R., Liu, C. M., Tran, Q., Routh, S., Smith, T. R., Mekary, R. A., & Broekman, M. L. D. (2018). Depression and survival of glioma patients: A systematic review and meta-analysis. Clinical Neurology and Neurosurgery, 172, 8–19. https://doi.org/10.1016/j.clineuro.2018.06.016
  • Tibbs, M. D., Huynh-Le, M. P., Reyes, A., Macari, A. C., Karunamuni, R., Tringale, K., Burkeen, J., Marshall, D., Xu, R., McDonald, C. R., & Hattangadi-Gluth, J. A. (2020). Longitudinal analysis of depression and anxiety symptoms as independent predictors of neurocognitive function in primary brain tumor patients. International Journal of Radiation Oncology, Biology, Physics, 108(5), 1229–1239. https://doi.org/10.1016/j.ijrobp.2020.07.002
  • Wang, Q., Qi, F., Song, X., Di, J., Zhang, L., Zhou, Y., Lu, X., Chang, J., & Yu, Y. (2018). A prospective longitudinal evaluation of cognition and depression in postoperative patients with high-grade glioma following radiotherapy and chemotherapy. Journal of Cancer Research and Therapeutics, 14(Supplement), S1048–S1051. https://doi.org/10.4103/0973-1482.199431
  • Wang, X., Chen, D., Qiu, J., Li, S., & Zheng, X. (2021). The relationship between the degree of brain edema regression and changes in cognitive function in patients with recurrent glioma treated with bevacizumab and temozolomide. Quantitative Imaging in Medicine and Surgery, 11(11), 4556–4568. https://doi.org/10.21037/qims-20-1084
  • Wang, X., Wang, N., Zhong, L., Wang, S., Zheng, Y., Yang, B., Zhang, J., Lin, Y., & Wang, Z. (2020). Prognostic value of depression and anxiety on breast cancer recurrence and mortality: A systematic review and meta-analysis of 282,203 patients. Molecular Psychiatry, 25(12), 3186–3197. https://doi.org/10.1038/s41380-020-00865-6
  • Zhang, L. (2021). Anxiety and depression in recurrent gastric cancer: Their prevalence and independent risk factors analyses. Medicine (Baltimore), 100(51), e28358. https://doi.org/10.1097/MD.0000000000028358
  • Zhang, X., Yang, B., Shao, D., Zhao, Y., Sun, J., Li, J., Li, Y., & Cao, F. (2019). Longitudinal association of subjective prospective and retrospective memory and depression among patients with glioma. European Journal of Oncology Nursing: The Official Journal of European Oncology Nursing Society, 42, 1–6. https://doi.org/10.1016/j.ejon.2019.07.003
  • Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.